4-[[[3-[4-(hydroxymethyl)phenyl]imidazo[1,2-a]pyrazin-8-yl]amino]methyl]benzenesulfonamide;4-[[[3-(4-methoxyphenyl)imidazo[1,2-a]pyrazin-8-yl]amino]methyl]benzenesulfonamide;4-[8-(2-pyridin-4-ylethylamino)imidazo[1,2-a]pyrazin-3-yl]phenol
C59H55N15O7S2 — CID 157323305
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-[[[3-[4-(hydroxymethyl)phenyl]imidazo[1,2-a]pyrazin-8-yl]amino]methyl]benzenesulfonamide;4-[[[3-(4-methoxyphenyl)imidazo[1,2-a]pyrazin-8-yl]amino]methyl]benzenesulfonamide;4-[8-(2-pyridin-4-ylethylamino)imidazo[1,2-a]pyrazin-3-yl]phenol
4-[[[3-[4-(hydroxymethyl)phenyl]imidazo[1,2-a]pyrazin-8-yl]amino]methyl]benzenesulfonamide;4-[[[3-(4-methoxyphenyl)imidazo[1,2-a]pyrazin-8-yl]amino]methyl]benzenesulfonamide;4-[8-(2-pyridin-4-ylethylamino)imidazo[1,2-a]pyrazin-3-yl]phenol (PubChem CID 157323305) has the molecular formula C59H55N15O7S2 and a molecular weight of 1150.32 g/mol. Its IUPAC name is 4-[[[3-[4-(hydroxymethyl)phenyl]imidazo[1,2-a]pyrazin-8-yl]amino]methyl]benzenesulfonamide;4-[[[3-(4-methoxyphenyl)imidazo[1,2-a]pyrazin-8-yl]amino]methyl]benzenesulfonamide;4-[8-(2-pyridin-4-ylethylamino)imidazo[1,2-a]pyrazin-3-yl]phenol.
Molecular Properties
| Compound Name | 4-[[[3-[4-(hydroxymethyl)phenyl]imidazo[1,2-a]pyrazin-8-yl]amino]methyl]benzenesulfonamide;4-[[[3-(4-methoxyphenyl)imidazo[1,2-a]pyrazin-8-yl]amino]methyl]benzenesulfonamide;4-[8-(2-pyridin-4-ylethylamino)imidazo[1,2-a]pyrazin-3-yl]phenol |
|---|---|
| PubChem CID | 157323305 |
| Molecular Formula | C59H55N15O7S2 |
| Molecular Weight | 1150.32 g/mol |
| Exact Mass | 1149.39 |
| IUPAC Name | 4-[[[3-[4-(hydroxymethyl)phenyl]imidazo[1,2-a]pyrazin-8-yl]amino]methyl]benzenesulfonamide;4-[[[3-(4-methoxyphenyl)imidazo[1,2-a]pyrazin-8-yl]amino]methyl]benzenesulfonamide;4-[8-(2-pyridin-4-ylethylamino)imidazo[1,2-a]pyrazin-3-yl]phenol |
| SMILES | COc1ccc(-c2cnc3c(NCc4ccc(S(N)(=O)=O)cc4)nccn23)cc1.NS(=O)(=O)c1ccc(CNc2nccn3c(-c4ccc(CO)cc4)cnc23)cc1.Oc1ccc(-c2cnc3c(NCCc4ccncc4)nccn23)cc1 |
| InChI | InChI=1S/2C20H19N5O3S.C19H17N5O/c1-28-16-6-4-15(5-7-16)18-13-24-20-19(22-10-11-25(18)20)23-12-14-2-8-17(9-3-14)29(21,26)27;21-29(27,28)17-7-3-14(4-8-17)11-23-19-20-24-12-18(25(20)10-9-22-19)16-5-1-15(13-26)2-6-16;25-16-3-1-15(2-4-16)17-13-23-19-18(22-11-12-24(17)19)21-10-7-14-5-8-20-9-6-14/h2-11,13H,12H2,1H3,(H,22,23)(H2,21,26,27);1-10,12,26H,11,13H2,(H,22,23)(H2,21,27,28);1-6,8-9,11-13,25H,7,10H2,(H,21,22) |
| InChIKey | BEKRIKLACHCWJW-UHFFFAOYSA-N |
| XLogP | 7.96 |
| TPSA | 309.56 Ų |
| H-Bond Donors | 7 |
| H-Bond Acceptors | 20 |
| Rotatable Bonds | 17 |
| Heavy Atoms | 83 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1150.32 |
| LogP ≤ 5 | 7.96 |
| H-Bond Donors ≤ 5 | 7 |
| H-Bond Acceptors ≤ 10 | 20 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 157323305 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.